✦ LIBER ✦

2,4-Diaminopyrimidine inhibitors of c-Met kinase bearing benzoxazepine anilines

✍ Scribed by Craig A. Zificsak; Jay P. Theroff; Lisa D. Aimone; Mark S. Albom; Thelma S. Angeles; Rebecca A. Brown; Deborah Galinis; Jennifer V. Grobelny; Torsten Herbertz; Jean Husten; Laura S. Kocsis; Christine LoSardo; Sheila J. Miknyoczki; Seetha Murthy; Damaris Rolon-Steele; Ted L. Underiner; Kevin J. Wells-Knecht; Candace S. Worrell; Kelli S. Zeigler; Bruce D. Dorsey

Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 561 KB
Volume: 21
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2010.12.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fused bicyclic derivatives of 2,4-diamin

Fused bicyclic derivatives of 2,4-diaminopyrimidine as c-Met inhibitors

✍ Linda R. Weinberg; Mark S. Albom; Thelma S. Angeles; Jean Husten; Joseph G. Lisk 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 478 KB

4-Alkoxy-2,6-diaminopyrimidine Derivativ

4-Alkoxy-2,6-diaminopyrimidine Derivatives: Inhibitors of Cyclin Dependent Kinase 1 and 2.

✍ Ian R. Hardcastle; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 155 KB 👁 1 views

ChemInform Abstract: N3-Arylmalonamides:

ChemInform Abstract: N3-Arylmalonamides: A New Series of Thieno[3,2-b]pyridine Based Inhibitors of c-Met and VEGFR2 Tyrosine Kinases.

✍ Stephen Claridge; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 19 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

New Heterocyclic Analogues of 4-(2-Chlor

New Heterocyclic Analogues of 4-(2-Chloro-5-methoxyanilino)quinazolines as Potent and Selective c-Src Kinase Inhibitors.

✍ Bernard Barlaam; Mike Fennell; Herve Germain; Tim Green; Laurent Hennequin; Remy 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 32 KB 👁 1 views

The Development of Novel 1,2-Dihydro-pyr

The Development of Novel 1,2-Dihydro-pyrimido[4,5-c]pyridazine Based Inhibitors of Lymphocyte Specific Kinase (Lck).

✍ Mark Sabat; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 22 KB

Design and Synthesis of Some Novel 2,3,4

Design and Synthesis of Some Novel 2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indoles as Potential c-Met Inhibitors

✍ Lianbao Ye; Yuanxin Tian; Zhonghuang Li; Jiajie Zhang; Shuguang Wu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 German ⚖ 182 KB

## Abstract Since deregulation of the tyrosine‐kinase receptor c‐Met is implicated in several human cancers and is an attractive target for small‐molecule‐drug discovery, we report herein the synthesis of 2,3,4,5‐tetrahydro‐8‐[1‐(quinolin‐6‐ylmethyl)‐1__H__‐1,2,3‐triazolo[4,5‐__b__]pyrazin‐6‐yl]‐1_